English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Study finds higher daytime light exposure linked to lower dementia risk
+ Regulatory
A. J. Acosta | Jun 24, 2026

New study finds 340B hospitals have 47.5% greater total assets than non-340B hospitals
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Study finds brain imaging may improve TMS outcomes for depression treatment
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

FARE announces collaboration with Chef Tyler Florence to support food allergy community
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Takeda CEO Julie Kim outlines transitional year and focus on new product launches
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

David Engblom receives 2026 Onkel Adam Prize for sickness behavior research
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Eli Lilly expands partnership with Abbisko Therapeutics in $1.9 billion deal
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Big Pharma restructures amid patent cliffs and market pressures

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation